Spelling suggestions: "subject:"drugs, 8hinese dermatopharmacology"" "subject:"drugs, 8hinese radiopharmacology""
1 |
The comparison of anti-tumor proliferating effect of dried Cordyceps sinensis and cultivated Cordyceps militaris using water extracts of their mycelia and fruiting body.January 2010 (has links)
Wong, Ngan Yuk. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 114-128). / Abstracts in English and Chinese. / Thesis/Assessment Committee --- p.i / Declaration --- p.ii / Abstract (in English) --- p.iii / Abstract (in Chinese) --- p.v / Acknowledgments --- p.vi / Table of Contents --- p.vii / List of Abbreviations --- p.xi / List of Figures --- p.xiv / List of Tables --- p.xvi / Chapter 1. --- Literature review --- p.1 / Chapter 1.1. --- Introduction to Cordyceps --- p.1 / Chapter 1.2. --- Ingredients of Cordyceps and their related biological activities --- p.4 / Chapter 1.2.1. --- "Amino acids, peptides, proteins and polyamines" --- p.4 / Chapter 1.2.1.1. --- Proteins --- p.4 / Chapter 1.2.2. --- Saccharides and sugar derivatives --- p.7 / Chapter 1.2.2.1. --- Polysaccharides --- p.7 / Chapter 1.2.3. --- Nucleosides --- p.9 / Chapter 1.2.3.1. --- Cordycepin --- p.9 / Chapter 1.2.3.2. --- Adenosine --- p.12 / Chapter 1.2.4. --- Fatty acids and sterols --- p.14 / Chapter 1.2.5. --- Vitamins and inorganics --- p.15 / Chapter 1.3. --- Cordyceps and their related biological activities --- p.15 / Chapter 1.3.1. --- Cordyceps militaris --- p.15 / Chapter 1.3.2. --- Cordyceps sinensis --- p.17 / Chapter 1.4. --- Proteomic tools used to study the change in protein expression profiles --- p.21 / Chapter 1.4.1. --- Proteomic tools in studies of the change in protein expression --- p.21 / Chapter 1.4.2. --- Two-dimensional gel electrophoresis --- p.22 / Chapter 1.4.3. --- Mass spectrometry --- p.22 / Chapter 1.4.4. --- Current challenges --- p.23 / Chapter 2. --- Methodology --- p.25 / Chapter 2.1. --- Cultivation of Cordyceps militaris --- p.25 / Chapter 2.2. --- Preparation of Cordyceps extracts for anti-proliferation assay on cell lines --- p.26 / Chapter 2.2.1. --- Types of the extracts of Cordyceps --- p.26 / Chapter 2.2.2. --- Preparation of the Cordyceps extracts --- p.26 / Chapter 2.3. --- Anti-proliferation assay on cell lines for extract screening --- p.26 / Chapter 2.3.1. --- Cell lines and culturing condition --- p.26 / Chapter 2.3.2. --- Viable cell count using trypan blue exclusion method --- p.27 / Chapter 2.3.3. --- Anti-proliferation assay on cell lines using MTT assay --- p.28 / Chapter 2.3.4. --- Determination of the IC50 values --- p.30 / Chapter 2.3.5. --- Statistical Analysis --- p.30 / Chapter 2.4. --- Proteomic studies for HepG2 and Hs68 after the treatment of extracts --- p.30 / Chapter 2.4.1. --- Protein sample preparation of HepG2and Hs68 --- p.30 / Chapter 2.4.2. --- Protein quantitation --- p.31 / Chapter 2.4.3. --- 2D Gel electrophoresis --- p.33 / Chapter 2.4.4. --- Image analysis --- p.34 / Chapter 2.4.5. --- In gel digestion and MALDI-ToF MS --- p.35 / Chapter 2.5. --- Cell cycle analysis --- p.36 / Chapter 2.5.1. --- Cell samples preparation --- p.36 / Chapter 2.5.2. --- Popidium iodide staining --- p.36 / Chapter 2.5.3. --- Flow cytometry --- p.37 / Chapter 2.5.4. --- Statistical Analysis --- p.38 / Chapter 2.6. --- Western blotting --- p.38 / Chapter 2.6.1. --- Protein sample preparation of HepG2 and Hs68 --- p.38 / Chapter 2.6.2. --- SDS-PAGE --- p.38 / Chapter 2.6.3. --- Protein Transblotting --- p.39 / Chapter 2.6.4. --- Membrane Blocking and Antibody Incubations --- p.39 / Chapter 2.6.5. --- Detection of Proteins --- p.40 / Chapter 3. --- Results --- p.41 / Chapter 3.1. --- Investigation of anti-proliferating effect of Cordyceps extracts on HepG2 and Hs68 using MTT assays --- p.41 / Chapter 3.1.1. --- Cordyceps militaris fruiting body extract - CMFB --- p.41 / Chapter 3.1.2. --- Cordyceps militaris mycelia extract - CMM --- p.41 / Chapter 3.1.3. --- Cordyceps sinensis fruiting body extract - CSFB --- p.45 / Chapter 3.1.4. --- Cordyceps sinensis mycelia extract - CSM --- p.45 / Chapter 3.1.5. --- "Comparison of the anti-proliferation effects of the Cordyceps extracts CMFB, CMM, CSFB and CSM" --- p.49 / Chapter 3.2. --- "Investigation of anti-proliferating effect of Cordyceps militaris extracts on H292, Neuro2a and WIL2-NS using MTT assays" --- p.51 / Chapter 3.2.1. --- Cordyceps militaris fruiting body extract - CMFB --- p.51 / Chapter 3.2.2. --- Cordyceps militaris mycelia extract - CMM --- p.51 / Chapter 3.3. --- Changes in total protein expression profiles in cell lines --- p.56 / Chapter 3.3.1. --- Protein samples preparation --- p.56 / Chapter 3.3.2. --- 2D gel electrophoresis analysis of protein from cell lines --- p.56 / Chapter 3.3.2.1. --- HepG2 --- p.57 / Chapter 3.3.2.2. --- Hs68 --- p.58 / Chapter 3.3.3. --- Differentially expressed proteins identification --- p.66 / Chapter 3.3.3.1. --- HepG2 --- p.66 / Chapter 3.3.3.2. --- Hs68 --- p.67 / Chapter 3.4. --- Cell cycle analysis --- p.76 / Chapter 3.4.1. --- Cell samples preparation --- p.76 / Chapter 3.4.2. --- HepG2 --- p.76 / Chapter 3.4.3. --- Hs68 --- p.77 / Chapter 3.4.4. --- H292 --- p.77 / Chapter 3.5. --- Western blotting --- p.81 / Chapter 3.5.1. --- Protein samples preparation --- p.81 / Chapter 3.5.2. --- Detection of actin for protein loading normalization --- p.83 / Chapter 3.5.3. --- Detection of procaspase-3 and cleaved caspase-3 --- p.83 / Chapter 3.5.4. --- Detection of procaspase-7 and cleaved caspase-7 --- p.84 / Chapter 3.5.5. --- Detection of procaspase-9 and cleaved caspase-9 --- p.84 / Chapter 4. --- Discussion --- p.86 / Chapter 4.1. --- Anti-tumor proliferating effect of Cordyceps extracts --- p.86 / Chapter 4.2. --- Changes in total protein expression profiles in cell lines --- p.87 / Chapter 4.2.1. --- Differentially expressed proteins in HepG2 treated with fruiting body extract --- p.88 / Chapter 4.2.1.1. --- Heat shock 90kDa protein 1 beta (HSP90(β) --- p.89 / Chapter 4.2.1.2. --- Far upstream element-binding protein 1 (FUBP-1) --- p.90 / Chapter 4.2.1.3. --- RuvB-like 1 (RuvbLl) --- p.90 / Chapter 4.2.1.4. --- Acidic protein rich in leucine (APRIL) --- p.91 / Chapter 4.2.1.5. --- SET protein --- p.92 / Chapter 4.2.1.6. --- Enolase 1 (α-enolase) --- p.94 / Chapter 4.2.1.7. --- Aldolase A --- p.96 / Chapter 4.2.1.8. --- DNA-binding protein B --- p.96 / Chapter 4.2.1.9. --- Peroxiredoxin 1 (Prx 1) --- p.97 / Chapter 4.2.1.10. --- Proteasome activator subunit 1 iso form 1 --- p.99 / Chapter 4.2.1.11. --- Dehydrogenase/ reductase member 2 isoform 2 --- p.99 / Chapter 4.2.1.12. --- Protein disulfide isomerase- related protein 5 --- p.100 / Chapter 4.2.1.13. --- Annexin IV --- p.100 / Chapter 4.2.1.14. --- Enoyl Coenzyme A hydratase --- p.101 / Chapter 4.2.2. --- Differentially expressed proteins in HepG2 treated with mycelia extract --- p.102 / Chapter 4.2.2.1. --- Alpha actinin 4 --- p.102 / Chapter 4.2.2.2. --- SET translocation isoform 1 --- p.103 / Chapter 4.2.2.3. --- Acidic (leucine-rich) nuclear phosphoprotein 32 family member B (ANP32b) --- p.103 / Chapter 4.2.2.4. --- Endoplasmic reticulum protein 29 isoform 1 precursor (ERp29) --- p.103 / Chapter 4.2.2.5. --- Heterogeneous nuclear ribonucleoprotein H3 isoform b (hnRNP 2H9A) --- p.104 / Chapter 4.2.3. --- Differentially expressed proteins in Hs68 treated with fruiting body extract --- p.105 / Chapter 4.2.3.1. --- Lamin A/C isoform 2 --- p.105 / Chapter 4.2.3.2. --- Vimentin --- p.106 / Chapter 4.2.3.3. --- Tropomyosin 1 alpha chain isoform 4 --- p.107 / Chapter 4.2.3.4. --- Rho GDP dissociation inhibitor (GDI) alpha (RhoGDIα) --- p.109 / Chapter 4.2.3.5. --- Dihydropyrimidinase-like 2 (DRP-2) --- p.109 / Chapter 4.2.3.6. --- Keratin 7 (K7) --- p.110 / Chapter 4.2.4. --- Differentially expressed proteins in Hs68 treated with mycelia extract --- p.111 / Chapter 4.3. --- Cell cycle analysis --- p.111 / Chapter 4.4. --- Western blotting --- p.113 / Chapter 5. --- References --- p.114
|
2 |
Investigation of pharmacological anti-diabetic effect on selected traditional Chinese herbs.January 2005 (has links)
by Lam Fung Chun. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 187-202). / Abstracts in English and Chinese. / Abstract --- p.i / Abstract in Chinese --- p.iii / Acknowledgements --- p.v / Table of Contents --- p.vi / List of Abbreviations --- p.xiii / List of Tables --- p.xvii / List of Figures --- p.xviii / Publication --- p.xx / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Epidemiology of Diabetes Mellitus --- p.1 / Chapter 1.2 --- Definition of Diabetes Mellitus --- p.1 / Chapter 1.3 --- Glucose Homeostasis and Diabetes Mellitus --- p.2 / Chapter 1.4 --- Classification of Diabetes Mellitus --- p.6 / Chapter 1.4.1 --- Type 1 Diabetes Mellitus --- p.6 / Chapter 1.4.2 --- Type 2 Diabetes Mellitus --- p.7 / Chapter 1.4.3 --- Gestational Diabetes Mellitus --- p.8 / Chapter 1.4.4 --- Other specific types --- p.8 / Chapter 1.5 --- Diagnostic Criteria of Diabetes Mellitus --- p.9 / Chapter 1.6 --- Complications of Diabetes Mellitus --- p.11 / Chapter 1.7 --- Pharmacological Treatment of Diabetes --- p.12 / Chapter 1.7.1 --- Treatment for type 1 diabetes mellitus --- p.12 / Chapter 1.7.2 --- Treatment for Type 2 diabetes mellitus --- p.13 / Chapter 1.7.2.1 --- Sulfonylureas --- p.14 / Chapter 1.7.1.2 --- Meglitinides --- p.15 / Chapter 1.7.1.3 --- Biguanides --- p.15 / Chapter 1.7.1.4 --- Thazolidinediones --- p.16 / Chapter 1.7.1.5 --- α-Glucosidase inhibitor --- p.16 / Chapter 1.8 --- Diabetes and Traditional Chinese Medicine --- p.17 / Chapter 1.9 --- Objective of this project --- p.18 / Chapter Chapter 2 --- "Botanical, Preparation and Authentication of Traditional Chinese Herbs" --- p.22 / Chapter 2.1 --- Introduction --- p.22 / Chapter 2.2 --- Herbal Materials --- p.22 / Chapter 2.3 --- Authentication of Herbal Material --- p.30 / Chapter 2.4 --- Extraction Method --- p.32 / Chapter 2.4.1 --- Material and Methods --- p.32 / Chapter 2.4.2 --- Results --- p.32 / Chapter 2.4 --- Discussion --- p.32 / Chapter Chapter 3 --- In vitro Studies on Selected Traditional Chinese Herbs --- p.35 / Chapter 3.1. --- Introduction --- p.35 / Chapter 3.2 --- Hepatic Gluconeogenesis Studies --- p.36 / Chapter 3.2.1 --- Introduction --- p.36 / Chapter 3.2.2 --- Material and Methods --- p.41 / Chapter 3.2.2.1 --- Cell Culture of H4IIE --- p.41 / Chapter 3.2.2.2 --- Glucose Production Assay --- p.42 / Chapter 3.2.2.3 --- Bicinchoninic Acid (BCA) Protein Assay --- p.43 / Chapter 3.2.3 --- Results --- p.44 / Chapter 3.3 --- Intestinal Glucose Absorption Studies --- p.46 / Chapter 3.3.1 --- Introduction --- p.46 / Chapter 3.3.2 --- Material and Methods --- p.48 / Chapter 3.3.2.1 --- Preparation of BBMV --- p.48 / Chapter 3.3.2.1.1 --- Chemicals --- p.48 / Chapter 3.3.2.1.2 --- Method --- p.48 / Chapter 3.3.2.2 --- Preparation of Herbal Extracts --- p.50 / Chapter 3.3.2.3 --- BBMV Glucose Uptake Assay --- p.51 / Chapter 3.3.2.4 --- Bicinchoninic Acid (BCA) Protein Assay --- p.54 / Chapter 3.3.3 --- Results --- p.54 / Chapter 3.4 --- Fibroblast Glucose Uptake Studies --- p.57 / Chapter 3.4.1 --- Introduction --- p.57 / Chapter 3.4.2 --- Material and Methods --- p.58 / Chapter 3.4.2.1 --- Cell Culture of Hs68 --- p.58 / Chapter 3.4.2.2 --- 2-Deoxy-D-glucose Uptake Assay --- p.59 / Chapter 3.4.2.3 --- Bicinchoninic Acid (BCA) Protein Assay --- p.60 / Chapter 3.4.3 --- Results --- p.60 / Chapter 3.5 --- Adipocyte Glucose Uptake Studies --- p.63 / Chapter 3.5.1 --- Introduction --- p.63 / Chapter 3.5.2 --- Material and Methods --- p.65 / Chapter 3.5.2.1 --- Cell Culture of 3T3-L1 --- p.65 / Chapter 3.5.2.2 --- Differentiation of 3T3-L1 --- p.65 / Chapter 3.5.2.3 --- 2-Deoxy-D-glucose Uptake Assay --- p.66 / Chapter 3.5.2.4 --- Bicinchoninic Acid (BCA) Protein Assay --- p.68 / Chapter 3.5.3 --- Results --- p.69 / Chapter 3.6 --- Glucose Transporter Type 4 (GLUT4) Expression Studies --- p.71 / Chapter 3.6.1 --- Introduction --- p.71 / Chapter 3.6.2 --- Material and Methods --- p.48 / Chapter 3.6.2.1 --- Cell Culture of 3T3-L1 --- p.71 / Chapter 3.6.2.2 --- Differentiation of 3T3-L1 --- p.71 / Chapter 3.6.2.3 --- GLUT4 Expression Assay --- p.72 / Chapter 3.6.2.4 --- Preparation of RNA --- p.72 / Chapter 3.6.2.5 --- RT-PCR --- p.73 / Chapter 3.6.2.6 --- PCR Analysis on GLUT4 Expression --- p.74 / Chapter 3.6.2.7 --- Real-time PCR --- p.75 / Chapter 3.6.3 --- Results --- p.77 / Chapter 3.7 --- Discussion --- p.81 / Chapter 3.7.1 --- Discussion of Hepatic Gluconeogenesis Studies --- p.81 / Chapter 3.7.2 --- Discussion of Intestinal Glucose Absorption Studies --- p.82 / Chapter 3.7.3 --- Discussion of Fibroblast Glucose Uptake Studies --- p.83 / Chapter 3.7.4 --- Discussion of Adipocyte Glucose Uptake Studies --- p.84 / Chapter 3.7.5 --- Discussion of Glucose Transporter Type 4 (GLUT4) Expression Studies --- p.86 / Chapter 3.7.6 --- Conclusion --- p.87 / Chapter Chapter 4 --- Purification of Cortex Moutan --- p.90 / Chapter 4.1 --- Introduction --- p.90 / Chapter 4.1.1 --- Phytochemical Studies of Cortex Moutan --- p.90 / Chapter 4.2 --- Organic Extraction of Cortex Moutan --- p.93 / Chapter 4.2.1 --- Extraction Material and Methods --- p.93 / Chapter 4.2.2. --- Results --- p.93 / Chapter 4.3 --- BBMV Glucose Uptake Assay with Cortex Moutan Organic Extract (CM-C and CM-D) --- p.96 / Chapter 4.3.1 --- Material and Methods --- p.48 / Chapter 4.3.2 --- Results --- p.96 / Chapter 4.4 --- Fractionation of CM-C and CM-D --- p.98 / Chapter 4.4.1 --- Material and Methods --- p.98 / Chapter 4.4.1.1 --- Chemicals --- p.98 / Chapter 4.4.1.2 --- Methods --- p.98 / Chapter 4.4.2 --- Results --- p.100 / Chapter 4.5 --- BBMV Glucose Uptake Assay of CM-C and CM-D Sub-fractions --- p.105 / Chapter 4.5.1 --- Results --- p.105 / Chapter 4.6 --- Sulfonylation of CM-D1 --- p.107 / Chapter 4.6.1 --- Material and Methods --- p.107 / Chapter 4.6.1.1 --- Chemicals --- p.107 / Chapter 4.6.1.2 --- Methods --- p.107 / Chapter 4.6.2 --- Structure Elucidation of CM-D1s --- p.108 / Chapter 4.6.2.1 --- 1H-NMR Analysis --- p.108 / Chapter 4.6.3 --- BBMV Glucose Uptake Assay of CM-D1s --- p.108 / Chapter 4.6.4 --- Results --- p.108 / Chapter 4.7 --- "Structural Elucidation of CM-D3, CM-D4 and CM-D5" --- p.112 / Chapter 4.7.1 --- Material and Methods --- p.112 / Chapter 4.7.1.1 --- Mass Spectrometry --- p.112 / Chapter 4.7.1.2 --- 1H-NMR Analysis --- p.112 / Chapter 4.7.2 --- Results --- p.113 / Chapter 4.8 --- "BBMV Glucose Uptake Assay of Acetovallione, CM-D3,CM-D4 and CM-D5" --- p.116 / Chapter 4.8.1 --- Results --- p.116 / Chapter 4.9 --- Synthesis of CM-D3s --- p.118 / Chapter 4.9.1 --- Material and Methods --- p.118 / Chapter 4.9.1.1 --- Chemicals --- p.118 / Chapter 4.9.1.2 --- Methods --- p.118 / Chapter 4.9.2 --- Structure Elucidation of synthesized product --- p.119 / Chapter 4.9.3 --- Results --- p.119 / Chapter 4.10 --- Discussion --- p.121 / Chapter Chapter 5 --- In vivo Studies on Selected Herbs --- p.123 / Chapter 5.1 --- Introduction --- p.123 / Chapter 5.1.1 --- Diabetic Animal Models --- p.123 / Chapter 5.1.2 --- Neonatal Streptozotocin-induced Diabetic Rat Model --- p.125 / Chapter 5.2 --- Oral Glucose Tolerance Test (OGTT) --- p.126 / Chapter 5.2.1 --- Animal --- p.126 / Chapter 5.2.2 --- Rat Induction Material and Methods --- p.126 / Chapter 5.2.3 --- Testing Method for diabetic condition of rats --- p.127 / Chapter 5.3.4 --- Results --- p.128 / Chapter 5.3 --- Basal Glycaemia Test --- p.138 / Chapter 5.3.1 --- Animal --- p.138 / Chapter 5.3.2 --- Rat Induction Material and Methods --- p.138 / Chapter 5.3.3 --- Testing Method --- p.138 / Chapter 5.3.4 --- Results --- p.140 / Chapter 5.4 --- Discussion --- p.143 / Chapter Chapter 6 --- General Discussion --- p.147 / Chapter 6.1 --- Introduction --- p.147 / Chapter 6.2 --- Summary of Research Findings --- p.151 / Chapter 6.3 --- Result Interpretation --- p.152 / Chapter 6.3.1 --- Result Interpretation of In Vitro Studies --- p.152 / Chapter 6.3.2 --- Result Interpretation of Cortex Moutan Purification --- p.154 / Chapter 6.3.3 --- Result Interpretation of In Vivo Studies --- p.157 / Chapter 6.4 --- Limitations and Improvements --- p.161 / Chapter 6.5 --- Future Directions --- p.163 / Chapter 6.6 --- Conclusions --- p.169 / Appendices --- p.170 / References --- p.187
|
3 |
Immunomodulatory effects and toxicity of mimosa pudica, the sensitive plant.January 1993 (has links)
by Cheng Yuk Kwan, Anna. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1993. / Includes bibliographical references (leaves 104-112). / Acknowledgements / Table of Contents --- p.i / Abbreviations --- p.iv / Abstract --- p.vi / List of figures --- p.ix / List of tables --- p.xi / Chapter Chapter One: --- Introduction / Chapter 1.1 --- Objective and scope of the project --- p.1 / Chapter 1.2 --- Literature review of Mimosa pudica / Chapter 1.2.1 --- Morphology of Mimosa pudica --- p.3 / Chapter 1.2.2 --- Chemistry of Mimosa pudica --- p.5 / Chapter 1.2.3 --- Uses in traditional medicine --- p.5 / Chapter 1.2.4 --- Clinical and pharmacological studies of Mimosa pudica --- p.6 / Chapter 1.2.5 --- Toxicology of Mimosa pudica --- p.8 / Chapter 1.2.6 --- Characteristics and toxicology of mimosine --- p.9 / Chapter 1.3 --- Immunomodulation / Chapter 1.3.1 --- Overview of the immune system --- p.11 / Chapter 1.3.2 --- Strategies on the study of immunomodulation of Mimosa pudica --- p.13 / Chapter 1.4 --- Toxicology / Chapter 1.4.1 --- Principles of the toxicological assays / Chapter 1.4.1.1 --- LD50 --- p.17 / Chapter 1.4.1.2 --- Enzyme assays --- p.18 / Chapter 1.4.1.3 --- Subacute toxicity test --- p.24 / Chapter 1.4.1.4 --- Reproductive toxicity test --- p.25 / Chapter Chapter Two: --- Materials and methods / Chapter 2.1 --- Materials / Chapter 2.1.1 --- Mimosa pudica --- p.27 / Chapter 2.1.2 --- Animals --- p.27 / Chapter 2.1.3 --- Chemicals --- p.28 / Chapter 2.2 --- Methods / Chapter 2.2.1 --- Extraction of Mimosa pudica --- p.32 / Chapter 2.2.2 --- Assays for the immunomodulatory effects of Mimosa pudica / Chapter 2.2.2.1 --- Cell preparation / Chapter a) --- Splenocytes --- p.35 / Chapter b) --- Thymocytes --- p.35 / Chapter c) --- Macrophages --- p.36 / Chapter 2.2.2.2 --- Splenocyte proliferation --- p.37 / Chapter 2.2.2.3 --- Thymocyte proliferation --- p.38 / Chapter 2.2.2.4 --- Phagocytic activity of macrophages --- p.39 / Chapter 2.2.2.5 --- Release of IL-1 by macrophages --- p.40 / Chapter 2.2.2.6 --- Plaque forming cells --- p.41 / Chapter 2.2.2.7 --- Restoration on splenocyte blastogenesis of old mice --- p.42 / Chapter 2.2.3 --- Assays for the toxicity of Mimosa pudica / Chapter 2.2.3.1 --- LD50 --- p.43 / Chapter 2.2.3.2 --- Enzyme assays --- p.43 / Chapter 2.2.3.3 --- Subacute toxicity --- p.43 / Chapter 2.2.3.4 --- Reproductive toxicity --- p.44 / Chapter 2.2.4 --- Statistical analysis --- p.44 / Chapter Chapter Three: --- Results / Chapter 3.1 --- Immunomodulatory effects of Mimosa pudica / Chapter 3.1.1 --- In vitro study on the lymphocyte proliferation / Chapter 3.1.1.1 --- Splenocyte proliferation --- p.45 / Chapter 3.1.1.2 --- Thymocyte proliferation --- p.50 / Chapter 3.1.2 --- In vivo study on the lymphocyte proliferation --- p.53 / Chapter 3.1.3 --- Phagocytic activity of macrophages --- p.58 / Chapter 3.1.4 --- Release of IL-1 by macrophages --- p.64 / Chapter 3.1.5 --- Plaque forming cells --- p.67 / Chapter 3.1.6 --- Restoration on splenocyte blastogenesis of old mice --- p.69 / Chapter 3.2 --- Toxicity of Mimosa pudica / Chapter 3.2.1 --- LD50 --- p.72 / Chapter 3.2.2 --- Enzyme assays --- p.75 / Chapter 3.2.3 --- Subacute toxicity --- p.80 / Chapter 3.2.4 --- Reproductive toxicity --- p.85 / Chapter Chapter Four: --- General discussion on the immunomodulatory effects and toxicity of Mimosa pudica / Chapter 4.1 --- Immunomodulatory effects of Mimosa pudica --- p.88 / Chapter 4.2 --- Toxicity of Mimosa pudica --- p.95 / Chapter Chapter Five: --- Concluding remarks --- p.99 / References --- p.104 / Appendix --- p.113
|
4 |
The effects of danshen and danggui on pharmacokinetics and pharmacodynamics of warfarin.January 1992 (has links)
Angus Chun-tim Lo. / Thesis (M. Phil.)--Chinese University of Hong Kong, 1992. / Includes bibliographical references (leaves 138-147). / ACKNOWLEDGEMENTS --- p.i / LIST OF PUBLICATIONS --- p.ii / ABSTRACT --- p.iii / ABBREVIATIONS --- p.viii / Chapter CHAPTER 1 --- General Introduction --- p.1 / Chapter CHAPTER 2 --- The Effects of Danshen (Salvia miltiorrhiza) on Pharmacokinetics and Pharmacodynamics of Warfarin / Chapter 2.1 --- Introduction --- p.35 / Chapter 2.2 --- Materials and Methods --- p.42 / Chapter 2.3 --- Results --- p.54 / Chapter 2.4 --- Discussion --- p.64 / Chapter CHAPTER 3 --- The Effects of Danshen (Salvia miltiorrhiza) on Pharmacological Properties of the Stereoisomers of Warfarin / Chapter 3.1 --- Introduction --- p.68 / Chapter 3.2 --- Materials and Methods --- p.72 / Chapter 3.3 --- Results --- p.84 / Chapter 3.4 --- Discussion --- p.99 / Chapter CHAPTER 4 --- The Effects of Danggui (Angelica sinensis) on Pharmacokinetics and Pharmacodynamics of Warfarin / Chapter 4.1 --- Introduction --- p.104 / Chapter 4.2 --- Materials and Methods --- p.114 / Chapter 4.3 --- Results --- p.120 / Chapter 4.4 --- Discussion --- p.127 / Chapter CHAPTER 5 --- General Conclusion --- p.131 / REFERENCES --- p.138
|
5 |
Chemical, molecular and pharmacological assessment of saussurea lappa clarke. / CUHK electronic theses & dissertations collectionJanuary 2004 (has links)
Chen Feng. / "August 2004." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (p. 166-178). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.
|
Page generated in 0.0725 seconds